SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-246668
Filing Date
2017-08-03
Accepted
2017-08-03 06:31:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT d434243d424b5.htm 424B5 459080
2 GRAPHIC g434243g82r93.jpg GRAPHIC 117553
3 GRAPHIC g434243g88v35.jpg GRAPHIC 17300
  Complete submission text file 0001193125-17-246668.txt   645969
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211993 | Film No.: 171002701
SIC: 2836 Biological Products, (No Diagnostic Substances)